|
Volumn 78, Issue 3, 2004, Pages
|
Pericardial synovial sarcoma: 14-Year survival with multimodality therapy
|
Author keywords
32
|
Indexed keywords
DOXORUBICIN;
GEFITINIB;
TRABECTEDIN;
ADULT;
ARTICLE;
CANCER CHEMOTHERAPY;
CANCER DIAGNOSIS;
CANCER RADIOTHERAPY;
CANCER SURGERY;
CANCER SURVIVAL;
CASE REPORT;
CHIMERA;
CLINICAL FEATURE;
GENETIC TRANSCRIPTION;
HUMAN;
HUMAN TISSUE;
LABORATORY DIAGNOSIS;
MALE;
PERICARDIAL SYNOVIAL SARCOMA;
PRIORITY JOURNAL;
PROGNOSIS;
RECURRENT DISEASE;
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;
SARCOMA;
STERNOTOMY;
SURVIVAL RATE;
TUMOR BIOPSY;
ADULT;
CHEMOTHERAPY, ADJUVANT;
DIMETHOATE;
DISEASE PROGRESSION;
DOXORUBICIN;
DRUG ADMINISTRATION SCHEDULE;
HUMANS;
IFOSFAMIDE;
ISOQUINOLINES;
MAGNETIC RESONANCE IMAGING;
MALE;
MEDIASTINAL NEOPLASMS;
NEOPLASM RECURRENCE, LOCAL;
NEOPLASM, RESIDUAL;
PALLIATIVE CARE;
PERICARDIUM;
SARCOMA, SYNOVIAL;
TOMOGRAPHY, X-RAY COMPUTED;
TREATMENT OUTCOME;
|
EID: 4444302107
PISSN: 00034975
EISSN: None
Source Type: Journal
DOI: 10.1016/j.athoracsur.2004.02.011 Document Type: Article |
Times cited : (38)
|
References (5)
|